Building the medical world model
Emular Health is developing AI that simulates how a patient's health changes under a given drug, so pharma and biotech teams can see how a candidate is likely to perform before it enters a trial.
Designing drugs has become fast. Choosing which ones to test has not.
AI now designs drug candidates in months. Clinical trials still take years, and most still fail. The hard question has moved from what to make to which candidates to take forward.
A world model that simulates each patient's future under any treatment.
Give it a patient and a drug, and the model predicts how that patient's health will unfold with the drug, without it, and under the alternatives. Select a stage to see how it works.
structure
targets
knowledge
Built for the decisions that shape a drug's path to patients.
Asset Diligence
Is this candidate worth advancing?
Predict the effectiveness and safety of a drug candidate before an in-licensing deal or a phase transition.
Trial Optimisation
How should the trial be run?
Simulate thousands of protocol designs and select the one with the highest predicted probability of success.
Indication Expansion
Where else could this drug work?
Identify, evaluate and prioritise new medical uses for an existing drug.
Work with us
Emular Health is based in Oxford and partners directly with pharma and biotech companies. Tell us about the decision you are facing and we will come back to you within two business days.
Oxford, United Kingdom